TLIS - Talis Biomedical Corporation Stock Price, Fair Value and News
8.98USD-0.18 (-1.97%)Market Closed
Latest Insider Trading transactions for TLIS
| Datesorted ascending | Name | Buy/Sell | $ Value | # Shares | Avg. Price | Title |
|---|---|---|---|---|---|---|
| 2021-11-18 | Premium | bought | Premium | Premium | Premium | - |
| 2021-08-13 | Premium | sold | Premium | Premium | Premium | - |
| 2021-08-13 | Premium | acquired | Premium | Premium | Premium | - |
| 2021-05-17 | Premium | bought | Premium | Premium | Premium | - |
| 2021-05-14 | Premium | bought | Premium | Premium | Premium | - |
| 2021-02-17 | Premium | acquired | Premium | Premium | Premium | - |
| 2021-02-17 | Premium | bought | Premium | Premium | Premium | - |
| 2021-02-17 | Premium | acquired | Premium | Premium | Premium | - |
| 2021-02-17 | Premium | acquired | Premium | Premium | Premium | - |
| 2021-02-17 | Premium | bought | Premium | Premium | Premium | - |
| 2021-02-17 | Premium | bought | Premium | Premium | Premium | Chief Financial Officer |
| 2021-02-17 | Premium | bought | Premium | Premium | Premium | - |
| 2021-02-17 | Premium | acquired | Premium | Premium | Premium | Chief Executive Officer |
| 2021-02-17 | Premium | bought | Premium | Premium | Premium | Sr. Vice President, Operations |
| 2021-02-17 | Premium | bought | Premium | Premium | Premium | Chief of Staff, Sr. VP, Legal |
| 2021-02-17 | Premium | bought | Premium | Premium | Premium | Sr. Vice President, R&D |
| 2021-02-17 | Premium | acquired | Premium | Premium | Premium | - |
| 2021-02-17 | Premium | bought | Premium | Premium | Premium | - |